The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Option exercise(M) | 45K | — | $0 |
| Sep 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Sell(S) | 1K | $39.24 | $55K |
| Sep 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Sell(S) | 45K | $38.14 | $1.7M |
| Sep 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Option exercise(M) | 45K | $16.40 | $738K |
| Sep 15, 2026 | Glassman Robert | Director | Option exercise(M) | 9K | — | $0 |
| Sep 15, 2026 | Glassman Robert | Director | Sell(S) | 9K | $38.27 | $332K |
| Sep 15, 2026 | Glassman Robert | Director | Option exercise(M) | 9K | $22.31 | $193K |
| Sep 15, 2026 | Souverijns Wim | Chief Commercial Officer | Sell(S) | 6K | $38.99 | $237K |
| Sep 14, 2026 | Souverijns Wim | Chief Commercial Officer | Option exercise(M) | 20K | — | $0 |
| Sep 14, 2026 | Modig Berndt | Chief Executive Officer, Director | Sell(S) | 2K | $39.40 | $90K |
| Sep 14, 2026 | Lu Peng | President | Tax withholding(F) | 117 | $38.02 | $4K |
| Sep 14, 2026 | Souverijns Wim | Chief Commercial Officer | Option exercise(M) | 20K | $17.43 | $349K |
| Sep 14, 2026 | Souverijns Wim | Chief Commercial Officer | Sell(S) | 20K | $39.31 | $786K |
| Sep 11, 2026 | Lu Peng | President | Option exercise(M) | 15K | $2.59 | $39K |
| Sep 11, 2026 | Lu Peng | President | Sell(S) | 15K | $40.13 | $602K |
| Sep 11, 2026 | Lu Peng | President | Tax withholding(F) | 109 | $37.51 | $4K |
| Sep 10, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 30K | $8.05 | $242K |
| Sep 10, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 30K | $38.30 | $1.1M |
| Sep 10, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 8K | — | $0 |
| Sep 9, 2026 | Glassman Robert | Director | Option exercise(M) | 8K | $20.00 | $160K |
| Sep 9, 2026 | Glassman Robert | Director | Sell(S) | 8K | $37.55 | $300K |
| Sep 9, 2026 | Glassman Robert | Director | Option exercise(M) | 8K | — | $0 |
| Sep 8, 2026 | Lu Peng | President | Option exercise(M) | 15K | $2.59 | $39K |
| Sep 8, 2026 | Lu Peng | President | Sell(S) | 15K | $40.68 | $610K |
| Aug 14, 2026 | Modig Berndt | Chief Executive Officer, Director | Sell(S) | 2K | $34.77 | $80K |
| Aug 12, 2026 | Lu Peng | President | Tax withholding(F) | 117 | $34.42 | $4K |
| Aug 11, 2026 | Lu Peng | President | Tax withholding(F) | 109 | $34.84 | $4K |
| Jul 13, 2026 | Modig Berndt | Chief Executive Officer, Director | Sell(S) | 2K | $34.97 | $80K |
| Jul 12, 2026 | Lu Peng | Chief Medical Officer | Tax withholding(F) | 117 | $35.07 | $4K |
| Jul 11, 2026 | Lu Peng | Chief Medical Officer | Tax withholding(F) | 109 | $35.07 | $4K |
| Jun 30, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell(S) | 31K | $35.49 | $1.1M |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 3K | $2.59 | $8K |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 25K | $8.05 | $200K |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 28K | $35.48 | $989K |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 31K | $35.49 | $1.1M |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 25K | — | $0 |
| Jun 30, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 3K | — | $0 |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell(S) | 7K | $35.05 | $241K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 1K | $2.59 | $4K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 900 | $8.05 | $7K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 4K | $2.59 | $11K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 4K | $8.05 | $34K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 2K | $35.12 | $81K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 8K | $35.05 | $291K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 7K | $35.05 | $245K |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 4K | — | $0 |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 1K | — | $0 |
| Jun 29, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 4K | — | $0 |
| Jun 29, 2026 | Schikan Johannes Gerardus Christiaan Petrus | Director | Sell(S) | 2K | $35.10 | $84K |
| Jun 26, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 15K | $2.59 | $38K |
| Jun 26, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 15K | $34.00 | $500K |
| Jun 26, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 15K | — | $0 |
| Jun 25, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 15K | $2.59 | $39K |
| Jun 25, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 12K | $34.45 | $400K |
| Jun 25, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 3K | $35.09 | $119K |
| Jun 25, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 15K | — | $0 |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 1K | $2.59 | $4K |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 900 | $8.05 | $7K |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 2K | $35.12 | $81K |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 2K | $35.12 | $81K |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 900 | — | $0 |
| Jun 25, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 1K | — | $0 |
| Jun 18, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 300 | $2.59 | $777 |
| Jun 18, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 300 | $34.00 | $10K |
| Jun 18, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 300 | — | $0 |
| Jun 15, 2026 | Modig Berndt | Chief Executive Officer, Director | Sell(S) | 2K | $31.05 | $68K |
| Jun 15, 2026 | Modig Berndt | Chief Executive Officer, Director | Sell(S) | 100 | $31.46 | $3K |
| Jun 12, 2026 | Lu Peng | Chief Medical Officer | Tax withholding(F) | 117 | $32.20 | $4K |
| Jun 11, 2026 | Lu Peng | Chief Medical Officer | Tax withholding(F) | 109 | $31.51 | $3K |
| Jun 4, 2026 | Nijdam Anna | Principal Accounting Officer | Sell(S) | 3K | $30.87 | $82K |
| May 22, 2026 | Nijdam Anna | Principal Accounting Officer | Option exercise(M) | 6K | $20.00 | $110K |
| May 22, 2026 | Nijdam Anna | Principal Accounting Officer | Sell(S) | 6K | $30.74 | $169K |
| May 22, 2026 | Nijdam Anna | Principal Accounting Officer | Option exercise(M) | 6K | — | $0 |
| May 21, 2026 | Nijdam Anna | Principal Accounting Officer | Option exercise(M) | 2K | $20.00 | $37K |
| May 21, 2026 | Nijdam Anna | Principal Accounting Officer | Sell(S) | 2K | $30.60 | $56K |
| May 21, 2026 | Nijdam Anna | Principal Accounting Officer | Option exercise(M) | 2K | — | $0 |
| May 21, 2026 | Monges Viviane | Director | Sell(S) | 10K | $30.29 | $293K |
| May 21, 2026 | Nassif David W. | CFO / CLO | Sell(S) | 10K | $30.31 | $303K |
| May 20, 2026 | Bjork Elisabeth | Director | Option exercise(M) | 10K | $8.05 | $81K |
| May 20, 2026 | Bjork Elisabeth | Director | Sell(S) | 10K | $29.32 | $293K |
| May 20, 2026 | Bjork Elisabeth | Director | Option exercise(M) | 10K | — | $0 |
| May 18, 2026 | Modig Berndt | Chief Executive Officer, Director | Sell(S) | 2K | $29.22 | $67K |
| May 15, 2026 | Abele Stefan Andreas | Chief Technical Ops Officer | Sell(S) | 9K | $29.82 | $261K |
| May 15, 2026 | Glassman Robert | Director | Option exercise(M) | 5K | $22.31 | $119K |
| May 15, 2026 | Glassman Robert | Director | Sell(S) | 5K | $29.83 | $159K |
| May 15, 2026 | Glassman Robert | Director | Sell(S) | 5K | $29.82 | $139K |
| May 15, 2026 | Glassman Robert | Director | Option exercise(M) | 5K | — | $0 |
| May 15, 2026 | Souverijns Wim | Chief Commercial Officer | Sell(S) | 10K | $29.92 | $299K |
| May 12, 2026 | Lu Peng | Chief Medical Officer | Tax withholding(F) | 117 | $29.95 | $4K |
| May 11, 2026 | Lu Peng | Chief Medical Officer | Tax withholding(F) | 109 | $30.09 | $3K |
| May 1, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 14K | $2.59 | $37K |
| May 1, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 14K | $30.16 | $423K |
| May 1, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 143 | $31.00 | $4K |
| May 1, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 14K | — | $0 |
| May 1, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 143 | — | $0 |
| Apr 30, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 15K | $2.59 | $39K |
| Apr 30, 2026 | Lu Peng | Chief Medical Officer | Sell(S) | 15K | $30.24 | $454K |
| Apr 30, 2026 | Lu Peng | Chief Medical Officer | Option exercise(M) | 15K | — | $0 |
| Apr 30, 2026 | Lesage Anne | Chief Early Development | Option exercise(M) | 4K | $2.59 | $10K |
| Apr 30, 2026 | Lesage Anne | Chief Early Development | Sell(S) | 4K | $30.26 | $112K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: Pharvaris N.V., SEC CIK 0001830487. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under PHVS and shows every filing by that issuer.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-19. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for PHVS